Description Abingworth believes scientific excellence is worth investing in. The company is a venture capital firm focused on all stages of life science investments and health care businesses in Europe, the US, and Asia. It typically invests from $20 million to $80 million over the life of its involvement, a span of time averaging three to eight years. Portfolio holdings include drug developer Amarin, medical device maker Lombard Medical Technologies, and diagnostics firm Epigenomics. The company has invested in companies engaged in structural biology, neuroscience, cell biology, gene therapy, and health care services. Abingworth has about $1.25 billion under management; it has established nine funds since 1973.